The Global Vaccines Market was valued at US$ 145.6 billion in 2022 and is expected to reach US$ 151.5 billion by 2030, exhibiting a CAGR of 1.4% during the forecast period (2023-2030).
The vaccines market is at the forefront of a transformative journey, delivering life-saving solutions that protect individuals and communities worldwide. The increasing number of patients with diseases such as tuberculosis and infectious diseases is majorly driving market growth.
Key players operating in the global vaccines market include Merck & Co., Inc., Emergent Bio Solutions, GlaxoSmithKline, Novartis, Sanofi Pasteur, Seqirus, Pfizer, CSL Limited, Jhonson & Jhonson, and Serum Institute of India Pvt Ltd. These key players are focused on adopting various growth strategies such as acquisitions collaborations, and product launches.
Key Developments in the Global Vaccines Market
In April 2023, Valneva launched its COVID-19 vaccine, which is now available in the United Kingdom and other countries. The vaccine is a live-attenuated vaccine that is different from the mRNA and protein-based vaccines that are currently available.
In March 2023, GSK acquired Sierra Oncology, a developer of cancer vaccines. The acquisition will allow GSK to expand its portfolio of cancer vaccines.
In 2022, Pfizer launched a new vaccine against rotavirus called RotaTeq. It protects against rotavirus, which is a leading cause of diarrhea in infants and young children.
|
Report Metrics |
Details |
|
CAGR |
1.4% |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (USD) |
|
Segments Covered |
By Vaccines Type, By Route of Administration, By Disease, By Age, By Distribution Channel, and By Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
|
Fastest Growing Region |
Asia-Pacific |
|
Largest Region |
North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other Key insights. |
For More Insights about the Market Request Free Sample: https://www.datamintelligence.com/download-sample/vaccines-market
Vaccines Market: Overview
Vaccines are the foundation of preventive medicine, playing a pivotal role in combating infectious diseases and reducing their impact on public health.
The vaccines market encompasses a wide range of immunization products, from childhood vaccines that protect against diseases like measles, mumps, and rubella to cutting-edge vaccines addressing emerging health threats like COVID-19.
Advancements in vaccine research and development have accelerated the timeline for bringing life-saving immunizations to market. Cutting-edge technologies, such as mRNA-based vaccines, have emerged as game-changers, enabling rapid vaccine production and high efficacy rates.
As a result, the vaccines market is better equipped than ever to respond to emerging health threats swiftly and effectively.
Vaccines Market: Opportunities
Expanding immunization programs and increasing government initiatives to promote vaccination offers growth opportunities for the vaccines market.
Achieving global health equity and extending access to vaccines for underserved populations open doors for new market frontiers. Moreover, research and development investments further pave the way for novel vaccines targeting various diseases.
Opportunities also lie in targeting neglected diseases, developing personalized vaccines, and exploring combination vaccines for enhanced efficiency.
Vaccines Market: Dynamics
The rise of emerging infectious diseases and the need to address new health threats fuel demand for innovative vaccines, thereby driving the vaccines market growth.
Moreover, new product launches and development by key players boost the market growth. For instance, in July 2021, GSK received US FDA approval for Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or will be at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.
However, the side effects of vaccines are expected to hamper the market growth.
Vaccines Market: Geographical Insights
North America holds a dominant position in the vaccines market and is expected to retain its position over the forecast period. Advanced healthcare infrastructure, strong government support for vaccination programs, and a high level of public awareness regarding the importance of immunization drive the market growth in this region.
Moreover, North America is a hub for vaccine research and development, with numerous pharmaceutical companies and research institutions driving innovation.
Table of Contents
|
1 |
Report Methodology and Scope |
|
2 |
Report Definition and Overview |
|
3 |
Executive Summary |
|
4 |
Market Dynamics |
|
5 |
Industry Factors |
|
6 |
COVID-19 Analysis |
|
7 |
Vaccines Market Segments and Region |
|
8 |
Global Company Share Analysis – 10 Key Companies |
|
9 |
Vaccines Market Company and Product Profiles |
|
10 |
About DataM |
Related Reports
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Send Email
Phone: 08774414866
Address:DATAM INTELLIGENCE 4MARKET RESEARCH LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039
City: HYDERABAD
State: Telangana
Country: India
Website: https://www.datamintelligence.com/research-report/vaccines-market